Literature DB >> 110691

Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor.

K Morihara, H Tsuzuki, K Oda.   

Abstract

The present study indicates that crystalline elastase of Pseudomonas aeruginosa is a very potent inactivator of human plasma alpha 1-proteinase inhibitor, the enzyme (E) inactivated the inhibitor (I) almost completely within 1 h at 25 degrees C at a molar ratio of E/I = 1:100. The crystalline P. aeruginosa protease also inactivated the inhibitor, but 100-fold less. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis indicated that the alpha 1-proteinase inhibitor inactivated by the elastase and protease showed decreases in molecular weight of approximately 5,000 and 10,000, respectively. Regeneration of trypsin was negligible even when bovine trypsin-alpha 1-proteinase inhibitor complex (E/I = 1.0) was treated with the elastase. The affinity of alpha 1-proteinase inhibitor to trypsin was much higher than that to elastase. It was suggested that, assuming the pseudomonal proteases are produced and can inactivate alpha 1-proteinase inhibitor in vivo during pseudomonal diseases, the loss of alpha 1-proteinase inhibitor activity may permit the endogenous serine proteases to cause tissue destruction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 110691      PMCID: PMC414282          DOI: 10.1128/iai.24.1.188-193.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Rabbit corneal damage produced by Pseudomonas aeruginosa infection.

Authors:  L D Gray; A S Kreger
Journal:  Infect Immun       Date:  1975-08       Impact factor: 3.441

2.  Phosphoramidon as an inhibitor of elastase from Pseudomonas aeruginosa.

Authors:  K Morihara; H Tsuzuki
Journal:  Jpn J Exp Med       Date:  1978-02

3.  Human plasma alpha1-proteinase inhibitor: temporary inhibition and multiple molecular forms of the complex with porcine trypsin.

Authors:  K Oda; M Laskowski; L F Kress; D Kowalski
Journal:  Biochem Biophys Res Commun       Date:  1977-06-20       Impact factor: 3.575

4.  Inactivation of human alpha 1-proteinase inhibitor by thiol proteinases.

Authors:  D Johnson; J Travis
Journal:  Biochem J       Date:  1977-06-01       Impact factor: 3.857

5.  Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.

Authors:  J D Klinger; D C Straus; C B Hilton; J A Bass
Journal:  J Infect Dis       Date:  1978-07       Impact factor: 5.226

6.  Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection.

Authors:  Y Hirao; J Y Homma
Journal:  Jpn J Exp Med       Date:  1978-02

7.  Large-scale purification and characterization of the exotoxin of Pseudomonas aeruginosa.

Authors:  S H Leppla
Journal:  Infect Immun       Date:  1976-10       Impact factor: 3.441

8.  Production of protease and elastase by Pseudomonas aeruginosa strains isolated from patients.

Authors:  K Morihara; H Tsuzuki
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

9.  Effectiveness of immunization with single and multi-component vaccines prepared from a common antigen (OEP), protease and elastase toxoids of Pseudomonas aeruginosa on protection against hemorrhagic pneumonia in mink due to P. aeruginosa.

Authors:  J Y Homma; C Abe; K Tanamoto; Y Hirao; K Morihara; H Tsuzuki; R Yanagawa; E Honda; Y Aoi; Y Fujimoto; M Goryo; N Imazeki; H Noda; A Goda; S Takeuchi; T Ishihara
Journal:  Jpn J Exp Med       Date:  1978-04

10.  The corneal response to Pseudomonas aeruginosa: histopathological and enzymatic characterization.

Authors:  E Kessler; B J Mondino; S I Brown
Journal:  Invest Ophthalmol Vis Sci       Date:  1977-02       Impact factor: 4.799

View more
  41 in total

1.  Transient aberrancy of alpha 1-antitrypsin glycoprotein microheterogeneity in Pseudomonas aeruginosa septicaemia.

Authors:  K Heyne; S Weidinger
Journal:  Infection       Date:  1990 Nov-Dec       Impact factor: 3.553

2.  Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease.

Authors:  C Kooi; C R Corbett; P A Sokol
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

3.  Degradation of soluble laminin and depletion of tissue-associated basement membrane laminin by Pseudomonas aeruginosa elastase and alkaline protease.

Authors:  L W Heck; K Morihara; D R Abrahamson
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

Review 4.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Efficient production and processing of elastase and LasA by Pseudomonas aeruginosa require zinc and calcium ions.

Authors:  J C Olson; D E Ohman
Journal:  J Bacteriol       Date:  1992-06       Impact factor: 3.490

Review 6.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 7.  alpha-1-Antitrypsin and the pathogenesis of emphysema.

Authors:  R A Stockley
Journal:  Lung       Date:  1987       Impact factor: 2.584

Review 8.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

9.  Proteolytic activity and fatal gram-negative sepsis in burned mice: effect of exogenous proteinase inhibition.

Authors:  A N Neely; R G Miller; I A Holder
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

10.  Pseudomonas aeruginosa lasB1 mutants produce an elastase, substituted at active-site His-223, that is defective in activity, processing, and secretion.

Authors:  K S McIver; J C Olson; D E Ohman
Journal:  J Bacteriol       Date:  1993-07       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.